Veradermics, Incorporated
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| -0.02 | – | – | -0.54 | -0.63 | -0.57 | -0.36 | -1.94 | |
| 0.00 | – | – | 0.00 | 0.03 | 0.14 | 0.09 | 0.24 | |
| 0.00 | – | – | 0.02 | -0.07 | 0.01 | 0.00 | -0.05 | |
| 0.00 | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | 0.43 | -2.94 | -2.71 | -6.86 | -11.71 | |
| -0.01 | – | – | – | 0.00 | – | – | – | |
| 0.25 | – | – | 0.03 | 4.00 | 7.21 | 10.95 | 21.33 | |
| 0.23 | – | – | -0.08 | 0.43 | 3.93 | 3.73 | 7.68 | |
| -0.02 | – | – | -0.54 | -0.63 | -0.57 | -0.36 | -1.94 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.